Jump to content

Jan Maree Tennent

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Chris the speller (talk | contribs) at 16:44, 28 June 2023 (→Career: replaced: Senior Research Scientist → senior research scientist, Program Manager → program manager). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Jan Tennent
Born
Melbourne, Victoria, Australia
AwardsBoard Diversity Scholarship, Australian Government Office for Women, Australian Institute of Company Directors (2013)
Perpetual Trust Scholarship (2011)
Scientific career
FieldsBiomedical Research and Innovation
Institutionsbiomedvic.org.au

Jan Maree Tennent FTSE (born 1 January 1960) is an Australian scientist in the biomedical and animal health research sectors, and a member of the Australian Academy of Technology Science and Engineering.[1][2]

Early life and education

Tennent was born in Footscray, Melbourne, Victoria on 1 January 1960. She obtained a Bachelor of Science, in microbiology from the Monash University in Melbourne in 1981. She completed her PhD in 1986 at Monash University. Her PhD thesis was entitled 'Molecular Analysis of Plasmids in Multi-resistant Staphylococci'.

Career

Tennent left Australia in 1986 to do a four-year postdoctoral fellowship with Prof Staffan Normark at Umeå University in Sweden. She researched the genetic mechanism and control of host attachment by uropathogenic Escherichia coli as part of the Normark laboratory's research.[3][4][5][6][7]

Tennet returned to Australia and joined the CSIRO as a senior research scientist. She became the program manager of the Vaccines and Immunology Group in 1997. Tennent has researched and given keynote presentations in the field of biotechnology and animal vaccines.[8]

In 2000, Tennent joined the global biotherapy organisation CSL Limited and later became a member of the CSL Animal Health executive team. Tennent joined the international pharmaceutical company Pfizer in 2004. In 2009, Tennent founded ConnectBio Pty Ltd.[9]

In 2011, Tennent was appointed as the Chief Executive Officer of Biomedical Research Victoria, a body that represents Australia's biomedical research. In 2017, Tennent was elected to the AusBiotech Board.[10]

Tennent has published 35 contributions in international peer-reviewed scientific journals (1984–2006) and eight reviews, theses and book chapters on microbial pathogenesis.[11] She served on research-related committees including the Genetic Manipulation Advisory Committee (now the Office of the Gene Technology Regulator) between 1995 and 2001.

Tennent worked at RMIT University and the University of Melbourne. In 2019, Tennent was elected Fellow of the Australian Academy of Technological Sciences and Engineering (FTSE).[12]

References

  1. ^ "Professor Jan Tennent – Biomedical research leader". ATSE. Retrieved 8 November 2019.
  2. ^ "Prof Jan Tennent FTSE – AusBiotech Ltd". www.ausbiotech.org. Retrieved 9 November 2019.
  3. ^ Marklund, Britt-lnger; Tennent, Jan M.; Garcia, Elisa; Hamers, Anja; Baga, Monika; Lindberg, Frederik; Gaastra, Wim; Normark, Staff an (August 1992). "Horizontal gene transfer of the Escherichia coli pap and prs pili operons as a mechanism for the development of tissue-specific adhesive properties". Molecular Microbiology. 6 (16): 2225–2242. doi:10.1111/j.1365-2958.1992.tb01399.x. PMID 1357526. S2CID 34556027.
  4. ^ Tennent, J. M.; Lindberg, F.; Normark, S. (May 1990). "Integrity of Escherichia coli P pili during biogenesis: properties and role of PapJ". Molecular Microbiology. 4 (5): 747–758. doi:10.1111/j.1365-2958.1990.tb00645.x. PMID 1975085. S2CID 27745334.
  5. ^ Lindberg, F; Tennent, J M; Hultgren, S J; Lund, B; Normark, S (November 1989). "PapD, a periplasmic transport protein in P-pilus biogenesis". Journal of Bacteriology. 171 (11): 6052–6058. doi:10.1128/jb.171.11.6052-6058.1989. PMC 210471. PMID 2572580.
  6. ^ Hultgren, S. J.; Lindberg, F.; Magnusson, G.; Kihlberg, J.; Tennent, J. M.; Normark, S. (1 June 1989). "The PapG adhesin of uropathogenic Escherichia coli contains separate regions for receptor binding and for the incorporation into the pilus". Proceedings of the National Academy of Sciences. 86 (12): 4357–4361. Bibcode:1989PNAS...86.4357H. doi:10.1073/pnas.86.12.4357. PMC 287268. PMID 2567514.
  7. ^ Norgren., M.; Bága., M.; Tennent, J.M.; Normark, S. (September 1987). "Nucleotide sequence, regulation and functional analysis of the papC gene required for cell surface localization of Pap pili of uropathogenic Escherichia coli". Molecular Microbiology. 1 (2): 169–178. doi:10.1111/j.1365-2958.1987.tb00509.x. PMID 2897064. S2CID 24884461.
  8. ^ "Jan Tennent – Melbourne Knowledge Week 2019". Jan Tennent – Melbourne Knowledge Week 2019. Retrieved 9 November 2019.
  9. ^ "ABN Lookup". November 2014.
  10. ^ "Prof Jan Tennent elected to AusBiotech Board – Biomedical Research Victoria". biomedvic.org.au. Archived from the original on 20 March 2018.
  11. ^ Search Results for author Tennent J on PubMed.
  12. ^ "Professor Jan Tennent – Biomedical research leader". Applied. Retrieved 24 October 2019.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Jan_Maree_Tennent&oldid=1162362281"